Originally posted here: Guerbet: First-half 2023 revenue
Originally posted here: Guerbet: First-half 2023 revenue
See more here: Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
Go here to read the rest: Sagimet Biosciences Announces Leadership Changes
View post: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit...
See the article here: Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
The rest is here: Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
Here is the original post: Travere Therapeutics to Report Second Quarter 2023 Financial Results
More here: Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
Here is the original post: Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program
Recent Comments